George Putnam
The Turnaround Letter
Geoffrey Seiler
Bullmarket.com
Chuck Carlson
The DRIP Investor
Nicholas Vardy
Bull Market Alert

Insiders target Zoran (ZRAN)


Bookmark and Share

 Recent corporate insider buying at tech company Zoran (NASDAQ: ZRAN) has attracted the attention of Paul McWilliams. Here's the "inside story" from his Next Inning service.

For the most part, there's not been that much activity in the overall technology sector. However, I noticed that the CEO at Zoran had stepped up to the plate recently with a $98K buy.

"And, when looking more closely, I noticed that two directors have also been recent buyers, one for $43K and the other for $68K.

Advertisement
Banner

"While the aggregate dollar amount here isn't huge, for a company the size of ZRAN and when considering there were three different buyers, it shows at the very least confidence.

" In addition to this, CEO Levy Gerzberg has shown good timing in his insider activity going back to 2005. In looking at his record we can see that sells were made in 2005, 2006 and 2007 at prices ranging from $20.19 to $27.31.

"Between these, a large buy was executed in 2006 at $12.36. More recently we saw him as a buyer in 2008 at $8.28 and $8.30 and then again last week at $9.80.

"With comfortably more than $7 in balance sheet value, I think the downside for ZRAN is reasonably cushioned.

"Zoran is involved in digital entertainment and digital imaging products. I think ZRAN's exposure to the flat panel TV market via its Supra TV processor is being underestimated by Wall Street.

"Therefore, I think there is some reasonable room for a near-term upside to the rather dismal expectations listed from the 11 covering analysts.

"Based on this thinking and the vote of confidence implied by three insider buyers, I think there is room to speculate here for a price in the mid-teens during the coming year."


News Flash

Goldcorp: 'My favorite major'
by Curtis Hesler, editor Professional Timing Service

The secular bull in gold and the commodity sector is not over. However, it is not at the ground floor any longer either; as such, stock selection must be more carefully considered.


Read more...

 

Money manager's small cap buys
by Jim Oberweis Jr., editor The Oberweis Report

Small-cap growth stock valuations are cheap, and like most things in life, economies are cyclical, even if this is a long and painful one. For the rare, brave contrarian with a reasonably long time horizon, that spells opportunity.


Read more...


   

Opportunities in homebuilding?
by Bernie Schaeffer, editor Schaeffer's Investment Research

Based on our "expectational analysis" strategy -- which  combines fundamental, sentiment and technical metrics -- I initiated long positions in two homebuilding stocks: Lennar Corporation (LEN) and Toll Brothers (TOL).


Read more...

 

Cliffs Natural: A DRIP favorite
by Vita Nelson, editor MoneyPaper

Our latest featured dividend reinvestment stock is Cliffs Natural Resources (CLF). Founded in 1847, the former Cleveland-Cliffs is the largest producer of iron ore pellets in North America.


Read more...

 

S&P's trio of info tech ETFS
by Dylan Cathers, S&P Capital IQ Equity Analyst, S&P The Outlook

Information technology is one of four sectors that S&P Capital IQ’s Sector Strategy Group currently recommends investors overweight in their portfolios.


Read more...

 

Crescent Point: Bakken bet
by Brian Hicks, editor Wealth Advisory

Master Limited Partnerships (MLPs) are unique investments that combine the tax benefits of a limited partnership (LP) with the liquidity of common stock.


Read more...

 

Natural gas: A bottom?
by Jason Cimpl, editor Daily Profit

Natural gas has collapsed for the past four years and has been on a gradual decline for almost a decade. Prices topped near $16 in 2005 and then declined to $2. So did natural gas just bottom?


Read more...

 

FBR Focus bests 99% of peers
by Walter Frank, editor MoneyLetter

Funds that invest in a relatively few stocks or sectors are less diversified than broadly invested funds and their volatility can be much higher. But the team at FBR Focus (FBRVX) seems to be getting it right.


Read more...

 

Celgene: Catalysts ahead
by John McCamant, editor Medical Technology Stock Letter

Celgene (CELG) recently kicked off the 2012 JP Morgan Healthcare conference by pre-announcing 4Q11 results and providing 2012 guidance.


Read more...

 

Water, water
by Richard Band, editor Profitable Investing

In the current environment, investors should focus any new stock purchases on companies with recession-resistant franchises and generous dividends -- such as water utilities.


Read more...